Members Only Content

Subscribe to get full access

Free Preview

We’re back baby! But normal might not look the same going forward. It’s possible that the pandemic has changed certain behaviours. That will be good for some industries, bad for others, and just generally change the rules for many more. Maxx Chatsko joins Dan Kline to break down how this might work for investors. We’ll also check in on Intellia Therapeutics and take your questions.

related news & insights

  • February 14, 2025||0 min||||

    Novo Nordisk Deep Dive: February 2025

    Novo Nordisk Recommendation Feb 2025

  • February 1, 2025||4.9 min||||

    X’s Favorite Small-Cap Growth Stocks

    We did something special this month. In addition to sharing our 7investing Community's favorite new ideas, we also asked an [...]

  • January 30, 2025||10 min||||

    “Staying Focused”: Here’s Why STAAR Surgical Has 41% Upside

    See my previous Discounted Cash Flows for Coupang , Rocket Lab , Tesla, and The Trade Desk. Some investors describe [...]